News

Granite will focus on two antibody therapies, both targeting crucial players in the inflammatory cascade to address ...
"European price controls and austerity measures reduce the attractiveness of its markets," Novartis CEO Vas Narasimhan and ...
Roche on Tuesday said it would invest $50 billion in the United States over the next five years, a day before Swiss Finance ...
The investment would go toward high-tech research and development sites and new manufacturing facilities in Indiana, ...
Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...
Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...
Two days after pharma companies sounded an alarm that their investments were headed out of Europe, Novartis AG has announced plans to increase investment in the U.S. by $23 billion, bringing the total ...
Novartis says the new research campus in San Diego is expected to open sometime in 2028 or 2029, joining the drug maker’s other hubs in Cambridge, Massachusetts and Basel, Switzerland.
Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...
The Swiss pharmaceutical giant plans to build seven new facilities and expand others in an effort that will allow it to produce drugs entirely in the U.S.